{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:24:39Z","timestamp":1788931479690,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01DA-24-8946"],"award-info":[{"award-number":["N01DA-24-8946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA055825"],"award-info":[{"award-number":["R01DA055825"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110686","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:01:32Z","timestamp":1758056492000},"page":"110686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Xanomeline treatment attenuates cocaine self-administration in rats and nonhuman primates"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9753-5586","authenticated-orcid":false,"given":"Samuel A.","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Heslep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3203-1966","authenticated-orcid":false,"given":"Carol A.","family":"Paronis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-5246","authenticated-orcid":false,"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110686_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.physbeh.2017.10.018","article-title":"Estradiol increases choice of cocaine over food in Male rats","volume":"203","author":"Bagley","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110686_bib5","article-title":"Co-stimulation of muscarinic M1 and M4 acetylcholine receptors prevents later cocaine reinforcement in Male and female mice, but not place-conditioning","volume":"134","author":"Balakrishnan","year":"2024","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110686_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050023","article-title":"Effects of dopamine D1-like and D2-like agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions","volume":"148","author":"Caine","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00443407","article-title":"A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior","volume":"97","author":"Carroll","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-008-1222-8","article-title":"Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous d-amphetamine treatment in rats","volume":"200","author":"Chiodo","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib9","first-page":"81","article-title":"Understanding stimulant use and use disorders in a new era. Medical clinics of North America","volume":"106","author":"Ciccarone","year":"2022","journal-title":"Substance Use Disorders"},{"key":"10.1016\/j.neuropharm.2025.110686_bib10","article-title":"Is there a canonical cortical circuit for the cholinergic system? Anatomical differences across common model systems","volume":"12","author":"Coppola","year":"2018","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2025.110686_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jaba.2922","article-title":"Contingency management for monosubstance use disorders: systematic review and assessment of predicted versus obtained effects","volume":"58","author":"Davidson","year":"2025","journal-title":"J. Appl. Behav. Anal."},{"key":"10.1016\/j.neuropharm.2025.110686_bib12","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/s41386-019-0458-9","article-title":"Experimental design and analysis for consideration of sex as a biological variable","volume":"44","author":"Diester","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0376-8716(02)00327-7","article-title":"Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement","volume":"69","author":"Donny","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0306-4522(88)90251-5","article-title":"An anatomical study of cholinergic innervation in rat cerebral cortex","volume":"25","author":"Eckenstein","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110686_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13011-021-00350-5","article-title":"\u2018Resurgent\u2019, \u2018twin\u2019 or \u2018silent\u2019 epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America","volume":"16","author":"Fischer","year":"2021","journal-title":"Subst. Abuse Treat. Prev. Pol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib16","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.261583798","article-title":"Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice","volume":"98","author":"Gerber","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110686_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-8993(94)90383-2","article-title":"Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites","volume":"653","author":"Glick","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110686_bib18","first-page":"1439","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addictive Behaviors, Addictions 2004. Crossing Boundaries: Implications of Advances in Basic Sciences for the Management of Addiction"},{"key":"10.1016\/j.neuropharm.2025.110686_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008877-200002000-00010","article-title":"Alternative reinforcers differentially modify cocaine self-administration by humans","volume":"11","author":"Hart","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib20","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00424-021-02634-y","article-title":"Differential regulation of medium spiny and cholinergic neurons in the nucleus accumbens core by the insular and medial prefrontal cortices in the rat","volume":"473","author":"Hirose","year":"2021","journal-title":"Pflugers Arch. Eur. J Physiol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2014.11.003","article-title":"A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: effects of candidate \u2018agonist-based\u2019 medications on sensitivity to reinforcement","volume":"146","author":"Hutsell","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/adb.12206","article-title":"Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys","volume":"21","author":"Hutsell","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib23","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.3843-09.2010","article-title":"A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors","volume":"30","author":"Jeon","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110686_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2016.05.021","article-title":"Development of a translational model to screen medications for cocaine use disorder I: choice between cocaine and food in rhesus monkeys","volume":"165","author":"Johnson","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib25","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/npp.2012.99","article-title":"Sex differences in selecting between food and cocaine reinforcement are mediated by estrogen","volume":"37","author":"Kerstetter","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnmol.2018.00139","article-title":"Muscarinic M4 receptors on cholinergic and dopamine D1 receptor-expressing neurons have opposing functionality for positive reinforcement and influence impulsivity","volume":"11","author":"Klawonn","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110686_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2016.05.022","article-title":"Development of a translational model to screen medications for cocaine use disorder II: choice between intravenous cocaine and money in humans","volume":"165","author":"Lile","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1037\/pha0000302","article-title":"Pharmacological validation of a translational model of cocaine use disorder: effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys","volume":"28","author":"Lile","year":"2020","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110686_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-4522(89)90377-1","article-title":"The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat","volume":"31","author":"Meredith","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110686_bib30","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1523\/JNEUROSCI.21-14-05239.2001","article-title":"Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor","volume":"21","author":"Miyakawa","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110686_bib31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2019.10.007","article-title":"Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders","volume":"40","author":"Moran","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110686_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02244304","article-title":"Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure","volume":"105","author":"Nader","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008877-199212000-00010","article-title":"Choice between cocaine and food by rhesus monkeys: effects of conditions of food availability","volume":"3","author":"Nader","year":"1992","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00213-002-1202-3","article-title":"Cocaine- and food-maintained responding under a multiple schedule in rhesus monkeys: environmental context and the effects of a dopamine antagonist","volume":"163","author":"Nader","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib3","series-title":"Drug Overdose Death Rates","author":"National Institute on Drug Abuse","year":"2024"},{"key":"10.1016\/j.neuropharm.2025.110686_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.npp.1300096","article-title":"Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol","volume":"28","author":"Negus","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00213-005-2266-7","article-title":"Effects of punishment on choice between cocaine and food in rhesus monkeys","volume":"181","author":"Negus","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib38","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/cne.24409","article-title":"Immunolocalization of muscarinic M1 receptor in the rat medial prefrontal cortex","volume":"526","author":"Oda","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(02)01910-6","article-title":"Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens","volume":"448","author":"Onali","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(77)90084-3","article-title":"On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine","volume":"6","author":"Roberts","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110686_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2008.08.009","article-title":"Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy","volume":"99","author":"Rush","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110686_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during d-Amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.121.001045","article-title":"Role of efficacy as a determinant of locomotor activation by Mu opioid receptor ligands in female and Male mice","volume":"382","author":"Santos","year":"2022","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110686_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-011-2225-4","article-title":"Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice","volume":"216","author":"Schmidt","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib47","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1523\/JNEUROSCI.4726-08.2009","article-title":"Behavioral and neural changes after gains and losses of conditioned reinforcers","volume":"29","author":"Seo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110686_bib48","first-page":"1033","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.neuropharm.2025.110686_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00429-008-0176-2","article-title":"The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala","volume":"213","author":"Smith","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2025.110686_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00213-017-4797-0","article-title":"Effects of muscarinic M1 and M4 acetylcholine receptor stimulation on extinction and reinstatement of cocaine seeking in male mice, independent of extinction learning","volume":"235","author":"Stoll","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110686_bib1","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57)","year":"2022"},{"key":"10.1016\/j.neuropharm.2025.110686_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40265-024-02126-0","article-title":"Xanomeline\/trospium chloride: first approval","volume":"85","author":"Syed","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2025.110686_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00213-008-1245-1","article-title":"Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats","volume":"201","author":"Thomsen","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib53","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/jpet.109.162057","article-title":"Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation","volume":"332","author":"Thomsen","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110686_bib54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-011-2516-9","article-title":"Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice","volume":"220","author":"Thomsen","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110686_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/jeab.15","article-title":"Cocaine versus food choice procedure in rats: environmental manipulations and effects of amphetamine","volume":"99","author":"Thomsen","year":"2013","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2025.110686_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-013-3256-9","article-title":"Acute and chronic effects of the M1\/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats","volume":"231","author":"Thomsen","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110686_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.117.241141","article-title":"Effects of acute and chronic treatments with dopamine D2 and D3 receptor ligands on cocaine versus food choice in rats","volume":"362","author":"Thomsen","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110686_bib58","first-page":"1163","article-title":"Distribution of central catecholaminergic neurons: a comparison between ungulates, humans and other species","volume":"13","author":"Tillet","year":"1998","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuropharm.2025.110686_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109110","article-title":"A drug-vs-food \u201cchoice\u201d self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders","volume":"354","author":"Townsend","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2025.110686_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s007260070051","article-title":"The medial prefrontal cortex as a part of the brain reward system","volume":"19","author":"Tzschentke","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2025.110686_bib61","first-page":"1087","article-title":"Induction and maintenance of ethanol self-administration in cynomolgus monkeys (Macaca fascicularis): long-term characterization of sex and individual differences","volume":"25","author":"Vivian","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110686_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4522(79)90083-6","article-title":"The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat","volume":"4","author":"Walaas","year":"1979","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110686_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/1064-1297.15.4.309","article-title":"The value of nonhuman Primates in drug abuse research","volume":"15","author":"Weerts","year":"2007","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110686_bib64","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41386-020-0684-1","article-title":"Effects of muscarinic M1 receptor stimulation on reinforcing and neurochemical effects of cocaine in rats","volume":"45","author":"Weikop","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib65","series-title":"Progress in Brain Research, Chemical Signalling in the Basal Ganglia","first-page":"25","article-title":"Chapter 2 cholinergic neurons of the rat and primate striatum are morphologically different","author":"Yelnik","year":"1993"},{"key":"10.1016\/j.neuropharm.2025.110686_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.npp.1380235","article-title":"Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia","volume":"12","author":"Yeomans","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110686_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1871524914666141226103135","article-title":"Estradiol, dopamine and motivation","volume":"14","author":"Yoest","year":"2014","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:44:14Z","timestamp":1760186654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":65,"alternative-id":["S0028390825003946"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110686","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xanomeline treatment attenuates cocaine self-administration in rats and nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110686"}}